Investor's Business Daily on MSN
Stocks with rising relative price strength: Enliven Therapeutics
Enliven Therapeutics shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 73 to 84.
Investor's Business Daily on MSN
PulteGroup shows improved relative price performance; still shy of benchmark
PulteGroup earns the No. 2 rank among its peers in the Building-Residential/Commercial industry group. Toll Brothers TOL is ...
Jason Fernando is a professional investor and writer who enjoys tackling and communicating complex business and financial problems. Somer G. Anderson is CPA, doctor of accounting, and an accounting ...
The U.S. stock market continues to show strength despite recent concerns over the nation's credit downgrade and fiscal outlook. Over the past few days, major indexes finished higher, driven by ...
The U.S. stock market has been on a remarkable run, with major indexes hitting fresh record highs last week after the Fed delivered its first rate cut of the year. The 25-basis-point reduction, which ...
As of Friday, January 09, Diginex Limited’s DGNX share price has dipped by 8.29%, which has investors questioning if this is ...
In the world of technical analysis, there is one reliable indicator for measuring market risk. The relative strength index measures overextension. Investors commonly use a lookback period of 14 days ...
Forbes contributors publish independent expert analyses and insights. John Navin is a Colorado-based journalist who writes about stocks. The S&P 500 on Friday hit another new high – it was brief as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results